Replies to post #26576 on Mymetics Corp (MYMX)

[Work Harder]

14. Bomsel M, Tudor D, Drillet AS, Alfsen A, Ganor Y, Roger MG, et al. Immunization With HIV-1 Gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates Against Vaginal SHIV Challenges. Immunity (2011) 34(2):269–80. doi: 10.1016/j.immuni.2011.01.015

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Leroux-Roels G, Maes C, Clement F, van Engelenburg F, van den Dobbelsteen M, Adler M, et al. Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated With HIV-1 Gp41 P1 Peptide on Virosomes. PloS One (2013) 8(2):e55438. doi: 10.1371/journal.pone.0055438

Catalent / Mymetics patent other publications pg 1

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167994043

MYM-V201

Second generation virosome-based HIV vaccine

on going

https://adisinsight.springer.com/drugs/800021858

Combined trial in men & women coming

Show us the money Ronnie

LOL